You are using an outdated browser. Please upgrade your browser to improve your experience.

We partner across the globe to address disease surveillance gaps.

Our Team

Mark Smolinski, MD, MPH


Mark Smolinski brings over 25 years of experience in applying innovative solutions to improve disease prevention and control across the globe. As president of Ending Pandemics, he leads a team of innovators working to improve early disease detection and rapid response in the planetary hotpots for emerging diseases.

Since 2009, Mark served as the Chief Medical Officer and Director of Global Health at the Skoll Global Threats Fund (SGTF), where he developed the Ending Pandemics in Our Lifetime Initiative in 2012. His work at SGTF created a solid foundation for the work of Ending Pandemics, which branched out as an independent entity on January 1, 2018.

Prior to SGTF, Mark was part of the starting team at, Google’s philanthropic arm. Working with a team of engineers, Google Flu Trends (a project that had tremendous impact on the use of big data for disease surveillance) was created in partnership with the U.S. Centers for Disease Control. Mark has served as Vice President for Biological Programs at the Nuclear Threat Initiative, a public charity directed by CNN founder Ted Turner and former U.S. Senator Sam Nunn. Before NTI, he led an 18-member expert committee of the National Academy of Medicine on the 2003 landmark report “Microbial Threats to Health: Emergence, Detection, and Response.” Mark served as the sixth Luther Terry Fellow in Washington, D.C., in the Office of the U.S. Surgeon General and as an Epidemic Intelligence Officer with the U.S. Centers for Disease Control and Prevention.

During COVID, Mark was appointed to the National Academy of Medicine’s Standing Committee on Emerging Threats in the 21st Century. Mark received his BS in Biology and MD from the University of Michigan in Ann Arbor. He is board-certified in preventive medicine and public health and holds an M.P.H. from the University of Arizona, where he was recognized as the 2016 Alumnus of the Year. Mark was on the investigation team that discovered hantavirus, a newly identified pathogen, in 1993. His passion for helping all peoples of the world save lives and improve livelihoods motivates partners on five continents.

Nomita Divi, MSPH

Executive Director

Nomita Divi brings 20 year expertise in stakeholder engagement, management, needs assessment, and program planning. Nomita oversees the implementation of a highly evolving work plan at Ending Pandemics.  Nomita developed a portfolio of projects while serving as Program Officer on the Ending Pandemics team at the Skoll Global Threats Fund, including network-building in South Asia, crowdsourcing epidemics intelligence for verification of outbreaks through EpiCore, and formulating creative opportunities to engage with technologists. Nomita spent eight years at Stanford University managing health policy programs and running a student fellowship to explore and document the ground realities that impact health seeking behavior in rural India. Before her time at Stanford, she worked at Massachusetts General Hospital, managing the application of a global HIV simulation model in India, South Africa, Cote d’Ivore, and the Caribbean.

Nomita holds a Bachelor of Science in Biology from the University of Ottawa, Canada as well as a Masters of Science in Public Health from the Harvard School of Public Health.

Onicio Leal Neto, MPH, PHD

Digital Innovations

Onicio Leal-Neto brings 12 years of experience in digital epidemiology and technologies applied to disease surveillance. He has worked for local governments in Brazil and several international organizations as consultant (Pan-American Health Organization, UNICEF, Inter-American Development Bank).

He led Participatory Disease Surveillance projects during the FIFA World Cup 2014 and Olympics 2016 and co-hosted important events like Epicrowd 2015 and Epihack Rio 2015. During Covid-19 pandemic, he was the chairman of Brasil Sem Corona, the biggest participatory disease surveillance strategy in Brazil. He was a project partner of the SURPRISE study, the first participatory disease surveillance approach for healthcare workers in 25 hospitals in Switzerland.

Onicio holds a bachelor’s degree in Biomedical Sciences, a Master’s degree and Ph.D. in Public Health & Epidemiology. He is a post-doc fellow at the Center for Child Well-being & Development – University of Zurich, co-leading wearables and machine learning projects for disease outbreaks and child development.

Jaś Mantero, MD, PhD

EpiCore and Surveillance Expert

Jaś Mantero supports Ending Pandemics in applying innovations to disease surveillance across hard to reach communities.

He has worked in the field of public health for the past 15 years with a focus on early detection, verification, assessment, and response at various agencies including the World Health Organization, European Centre for Disease Prevention & Control, Doctors without Borders (MSF), and the European Union.

Jaś works as an independent Public Health consultant covering epidemic intelligence and health risk assessment tasks for governmental institutions.

Prapapan Phetra


Prapapan Phetra has been working with the Ending Pandemics team on the planning and implementation of EpiHacks™ across the globe since 2012.

Prapapan runs her own software business in Thailand, Business On Network Co. Ltd., where she provides counsel and IT solutions with open-source technologies for NGOs, academia, public and private sector industries.

Marlo Libel, MD, MPH

Senior Advisor

Marlo Libel applies over 40 years of public health surveillance experience to the goal of ending pandemics. He provides sound advice and strategic direction, along with technical support to CORDS (Connecting Organizations for Regional Disease Surveillance) and EpiCore, a global crowdsourcing network of volunteer human, animal, and environmental practitioners committed to verifying disease outbreaks. Marlo previously worked with Ending Pandemics at the Skoll Global Threats Fund on a variety of projects. He led the SGTF project on participatory surveillance for early detection of disease outbreaks at mass gatherings (2014 World Cup and 2016 Olympics, both in Brazil).

Marlo was a medical epidemiologist at the Pan American Health Organization (PAHO/WHO) from 1985–2009. Initially stationed in Panama, he directed the technical cooperation in Central America to improve public health surveillance systems, outbreak investigation and control, and HIV/AIDS surveillance and prevention strategies. From 1989 onward, at PAHO’s headquarters in Washington, D.C., he served as regional advisor on communicable diseases with responsibility for coordinating PAHO’s response to disease outbreaks. His work also included establishing emerging infectious disease networks in the Southern Cone, the Amazon Basin, and Central America and acting as regional focal point for the implementation of IHR (2005). He received his MD from the Faculdade Catolica de Medicina de Porto Alegre, Brazil, and his MPH from the Tulane School of Tropical Medicine and Hygiene.


Our Advisory Board

Margaret Hamburg, MD

Board Chairperson

Dr. Hamburg is an internationally recognized expert in medicine and public health as well as a leading authority on emergency preparedness and response.

Currently, Dr. Hamburg is the Foreign Secretary for the National Academy of Medicine, where she serves as senior advisor on international matters and is the liaison with other Academies of Medicine around the world. She is also the President of the American Association for the Advancement of Science (AAAS), the world’s largest scientific membership organization.

Prior to this, President Obama appointed her to serve as Commissioner of the Food and Drug Administration (FDA). In this role she was known for advancing regulatory science, medical product innovation and the globalization of the agency, while also overseeing the implementation of groundbreaking laws to curb tobacco use and enhance food safety.

Previously, Dr. Hamburg served as Vice President and as a Senior Scientist at the Nuclear Threat Initiative, a foundation dedicated to reducing nuclear, chemical and biological threats. Dr. Hamburg also served as New York City Health Commissioner, where she undertook major initiatives to address HIV/AIDS, curtail the resurgence and spread of tuberculosis, and launched the nation’s first public health bioterrorism preparedness program. President Clinton later named her Assistant Secretary for Planning and Evaluation for the U.S. Department of Health and Human Services, the chief policy role in the department. Dr Hamburg also served as the Assistant Director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Larry Brilliant, MD, MPH

Dr. Larry Brilliant is the author of ‘Sometimes Brilliant: The Impossible Adventures of a Spiritual Seeker and Visionary Physician Who Helped Conquer the Worst Disease in History.’ He currently serves as the Chairman of the Advisory Board for Ending Pandemics. Larry is also a Senior Advisor at the Jeff Skoll Group. He previously served as the Skoll Global Threats Fund’s President and CEO, the Vice President of Google, and as a founding Executive Director of

Dr. Brilliant is board certified in preventive medicine and lived in India for more than a decade working as a United Nations medical officer where he played a key role in the successful World Health Organization (WHO) smallpox eradication program in South Asia. He is also the co-founder of The Seva Foundation, an international NGO with programs and grantees that have given back sight to more than 5 million blind people in over 20 countries.

He has worked with four Presidents, the United Nations, G8, and Chaired the National Biosurveillance Advisory Subcommittee. He co-founded one of the first digital social networks, the Well. He was also a professor at the University of Michigan and founding chairman of the National Biosurveillance Advisory Subcommittee.

Dr. Brilliant has been recognized as one of the “100 Most Influential People,” by Time Magazine, received the TED Prize, and has four honorary doctorates. He currently serves on the boards of Skoll Foundation, Salesforce Foundation, and Dharma Platform.

Donna Shalala, PhD

Donna E. Shalala is a distinguished educator and Trustee Professor of Political Science and Health Policy at the University of Miami.

One of the most honored academic leaders of her generation, she has been elected to seven national academies including the National Academy of Medicine, the National Academy of Education, The National Academy of Public Administration, the American Academy of Arts and Sciences, and the American Philosophical Society.

Professor Shalala is one of the country’s first Peace Corps Volunteers (Iran), her public service also includes serving as Secretary of the US Department of Health and Human Services in the Clinton administration for eight years. She co-chaired with Senator Bob Dole the President’s Commission on Care for America’s Returning Wooded Warriors. In 2008 President George W.

Bush selected her as the recipient of the Presidential Medal of Freedom, the nation’s highest civilian award. She was named one of “America’s Best Leaders” by U.S. News & World Report (2005), received the Nelson Mandela Award for Health and Human Rights (2010), and was inducted into the National Women's Hall of Fame (2011). She served one term in Congress

representing Florida’s 27 th District (2020-22). She has led three universities: Hunter College, 1980-87; University of Wisconsin-Madison, 1987-1993; and the University of Miami, 2001-2015.

Professor Shalala received her A.B. from Western College for Women and her PhD from The Maxwell School of Citizenship and Public Affairs at Syracuse University.

Alex Charlton, MBA

Alex Charlton is Chairman & Chief Executive Officer at Carlyle Global Partners. Carlyle Global Partners is part of the Finance industry, and located in New York, United States.

For over 25 years Alex has advised leading family wealth-holders and sovereign fund representatives in the United States, Europe and Asia on philanthropy and impact investment initiatives focused on wellness and the life sciences.

On behalf of clients, Alex has also curated by-invitation summits around the world, co-hosted by accomplished institutions, with participation by world-class life science innovators. Host institutions have included Stanford University, the Prince Albert II of Monaco Foundation, the University of California Santa Barbara, the John F. Kennedy Presidential Library and Museum, the Board of Trustees of Mount Vernon and the University of California San Francisco.

Previously he was Managing Director at NorthStar Capital Advisors Group LLC, Advisor at Europa Partners, and Regional Manager at Eli Lilly.

Alex received his MBA from the Cranfield School of Management and BSc from Newcastle University

Judy Wasserheit, MD, MPH

Judith N. Wasserheit, MD, MPH, is a Professor of Global Health, Medicine and Epidemiology at the University of Washington, where she played a central role in launching the Department of Global Health and served as Chair 2014-2022.

Dr. Wasserheit also serves as Co-Director for the UW Alliance for Pandemic Preparedness. She was the Founding Chief of the U.S. National Institute of Health’s (NIH’s) Sexually Transmitted Disease (STD) Research Branch; Director of the U.S. CDC’s STD/HIV Prevention Program, and Director of the HIV Vaccine Trials Network. She is a member of the US National Academy of Medicine, the American Epidemiological Society, and the Johns Hopkins Society of Scholars and was a London School of Hygiene & Tropical Medicine Heath Clark Endowed Lecturer.

Dr. Wasserheit has worked extensively at the interface of sexually transmitted infections (STI) and HIV clinical-epidemiological research, programs and policy in the U.S. and globally. She has worked in Bangladesh, China, Colombia, Egypt, Indonesia, Kenya, Peru, Thailand and Zambia. She has broad experience working with agencies, governments, and colleagues on STI, HIV and pandemic disease research, policy and programmatic issues. Her development of the concept of epidemiological synergy between HIV infection and other sexually transmitted infections has had a major influence on HIV prevention policy and programs worldwide. Her current interests include the design, conduct and translation of STI, HIV and pandemic disease research into high impact, large-scale, evidence-based policies, and programs.

Dr. Wasserheit earned her MD from Harvard University, her MPH from Johns Hopkins University, and her BA from Princeton University.

Keiji Fukuda, MD, MPH

Dr. Fukuda has worked in public health for over 30 years and is a global authority on emerging infectious diseases.

After training in clinical medicine, he worked at the Centers for Disease Control (CDC) for 20 years before joining the World Health Organization (WHO), where he became Director of the Global Influenza Programme and then Assistant Director General for Health Security. After WHO, he became Director of the School of Public Health at the University of Hong Kong.

His career covered the emergence of several diseases including HIV/AIDS, chronic fatigue syndrome, avian and pandemic influenza, SARS, MERS, the 2014 Ebola epidemic in West Africa, and antimicrobial resistance (AMR). He led numerous international field investigations and assessment missions, especially in China, conducted epidemiological research, managed national influenza surveillance, extensively conducted media communications and managed complex events including WHO’s global response to the H1N1 influenza pandemic, the first major test of the International Health Regulations. At both CDC and WHO, he was deeply involved with national pandemic preparedness planning.

Dr. Fukuda was central in negotiations to adopt the Pandemic Influenza Preparedness Framework and a historic 2016 Heads of State level meeting on AMR at the United Nations. During Covid-19, he was a member of several scientific and advisory bodies to the Hong Kong Government.

Dr. Fukuda received his BA from Oberlin College, MD from the University of Vermont, MPH from the University of California, Berkeley and EIS training at CDC

Suwit Wibulpolprasert, MD

Dr. Suwit Wibulpolprasert is a general practitioner, a public health specialist, an administrator, and a policy advocator. He was the Director of the Northeastern Public Health College, Director of Technical Division of the FDA, Director of Bureau of Health Policy and Planning, Assistant Permanent Secretary, Deputy Permanent Secretary and Senior Advisor at the Thai Ministry of Public Health.

He has been extensively involved in research and development covering many areas of health including human resources, economics, financing, international trade, information, advocacy, and pharmaceuticals. Dr. Wibulpolprasert has published more than 100 papers, reports, and books locally and internationally.

He currently chairs the Steering Committee of the Asia Partnership on Avian Influenza Research and the Steering Committee of the Asia-Pacific Action Alliance on Human Resources for Health. He is also a member and Chair of the Program Coordinating Board of the UNAIDS, and member and Chair of the Program and Policy Committee of the interim Board of the Global Health Workforce Alliance.

Dr. Wibulpolprasert served as a Deputy Permanent Secretary of the Thai Ministry of Public Health, in 2000-2003. Currently, he serves as the highest-ranking government official as a Senior Advisor in Disease Control, after serving as a Senior Advisor in Health Economics during 2003-2006. He is also responsible for Health Policy and International Health Works of the Ministry.